Abacus Global Management (ABX) Can't File Its Q3 2026 10-Q: Fund Credits May Change Reports Back to June 2025
Some links pay us a referral fee; each one says so. Disclosure
Filing alert · free
An email when Abacus Global Management files with the SEC
An email the day Abacus Global Management files something new, with the link to the document on the SEC site.
Quick answer
On November 17, 2026 Abacus Global Management, Inc. (NYSE: ABX; its 9.875% notes trade as ABXL; formerly Abacus Life, Inc.) told the SEC it cannot file its Form 10-Q for the quarter ended September 30, 2026 on time (Form 12b-25, accession 0001628280-26-074362). The reason it gives is its “ongoing evaluation of the accounting for capital account credits provided to the limited partners of certain private funds advised by the Company starting in the second quarter of 2025”, plus the accounting for certain transactions between the company and its related party funds. It says the corrections it may make could go back “potentially dating back to June 30, 2025”, that its disclosure controls and internal control over financial reporting may be found not effective, and that it will file “as soon as practicable, but not within the extended filing date pursuant to Rule 12b-25”. It gives no date and no estimate: the company “is unable to estimate the extent of any significant changes in previously filed reports, including the earnings release” of November 5, 2026. That release showed total revenue of $76,883,335 for the third quarter, of which $34,310,393 was life-solutions revenue from related-party funds, up from $8,585,697 a year earlier, and a related party payable of $3,288,000. As of November 19, 2026 no Form 10-Q, no Item 4.02 non-reliance 8-K and no exchange notice for this filing are on EDGAR. This is a delay and an evaluation, not a restatement: nothing has been corrected yet.
Key takeaways
- What was filed: a Form 12b-25 (NT 10-Q) on November 17, 2026. It names two open questions: the accounting for “capital account credits” given to limited partners of certain private funds Abacus advises since the second quarter of 2025, and the accounting for certain transactions between Abacus and its related party funds.
- How far back it could reach: after the evaluation the company will assess whether earlier periodic reports, “potentially dating back to June 30, 2025”, need correcting. That window covers five reports already on EDGAR: the 10-Qs for June 30 and September 30, 2025, the 10-K for 2025 and the 10-Qs for March 31 and June 30, 2026 (our list from the filing index).
- Which lines may move: the NT names “asset management revenue, related party” and “related party payables associated with the private funds’ limited partner incentives”. In the November 5, 2026 release, related-party asset management revenue was $4,229,927 for the quarter and $18,085,920 for nine months; related-party life-solutions revenue was $34,310,393 and $62,365,814.
- Size of the exposure, as a scale only: the two related-party revenue lines were 50.1% of third-quarter 2026 revenue and 38.4% of nine-month revenue (our arithmetic). The company has not said how much any of it would change, and it has not said these lines are wrong.
- Controls: the 2025 10-K concluded internal control over financial reporting was effective at December 31, 2025, and the Q2 2026 10-Q concluded disclosure controls were effective at June 30, 2026. The NT says a reassessment may reverse that. The auditor changed in March 2026 (Grant Thornton to KPMG, with no disagreements or reportable events reported in the 8-K).
- What has not been filed as of November 19, 2026: the Q3 10-Q, any 8-K under Item 4.02, and any filing that gives a new date. The $0.22 annual dividend declared November 5, 2026 (record date December 1, 2026, payable December 16, 2026) has not been withdrawn in any filing we found.
CSV · 69 rows
Abacus Global Management (ABX): the NT 10-Q, the related-party lines, the funds, the debt and the controls record
69 rows from the Form 12b-25 of November 17, 2026, three 2026 8-Ks, the Q2 2026 10-Q and the 2025 10-K, with the SEC accession number on every sourced row and our arithmetic labelled.
What the November 17, 2026 filing says, line by line
| Part of the NT 10-Q | What it says | What it leaves out |
|---|---|---|
| Period | Quarter ended September 30, 2026; Form 10-Q box ticked | Nothing about any other period being late |
| Part III, the reason | The delay is “a result of its ongoing evaluation of the accounting for capital account credits provided to the limited partners of certain private funds advised by the Company starting in the second quarter of 2025, as well as the accounting associated with certain transactions between the Company and its related party funds” | Which funds, how large the credits are, who decided on them, and which accounting rule is in question |
| Part III, next step | After the evaluation, the company “will evaluate the materiality of any identified issues in the Company’s previously filed periodic reports, potentially dating back to June 30, 2025, to determine whether corrections are required” | Whether any report will be restated |
| Part III, controls | A reassessment “may result in a conclusion that the Company’s disclosure controls and procedures and internal control over financial reporting were not effective” | Whether a material weakness exists |
| Part III, timing | It will file “as soon as practicable, but not within the extended filing date pursuant to Rule 12b-25” | Any date |
| Part IV(2) | All other periodic reports required in the last 12 months have been filed (Yes) | Nothing |
| Part IV(3) | A significant change in results is anticipated (Yes): “asset management revenue, related party, and related party payables associated with the private funds’ limited partner incentives” | Any number, even a range |
| Signature | Chief Financial Officer and Chief Operating Officer, November 17, 2026 | Any audit committee statement or auditor view |
Two details are easy to miss. First, Part IV does not say results will be better or worse; it says a significant change “may” follow and that no estimate can be made. Second, the company says the unknown reaches back to the earnings release of November 5, 2026, so the figures in that release are the company's own unaudited numbers that it now says may change.
Who the funds are, from Abacus's own filings
The NT does not name the funds. The Q2 2026 10-Q, filed August 10, 2026 (accession 0001628280-26-055287), describes the private vehicles Abacus works with and says what it calls a related party.
| Vehicle | What the Q2 2026 10-Q says | How Abacus is paid or exposed |
|---|---|---|
| Carlisle Funds | Luxembourg alternative investment funds managed by Carlisle: “two funds and seven sub-funds”; Abacus services their policies and does not consolidate them | Management fee of 50 to 200 basis points of AUM; servicing fee of $1,000 per policy per year; policy sales and purchases are related-party activity |
| LP Funds | Four limited partnerships Abacus established: Abacus Enhanced Income Fixed LP, Abacus Enhanced Income Plus LP, Abacus Premiere Income Fixed LP and Abacus Premiere Income Plus LP; not consolidated | Same 50 to 200 basis point management fee range; servicing fee of $996 per policy per year |
| Securitized Entity (2025 LMA LLC) | A bankruptcy-remote vehicle holding a static pool of policies that backs rated notes sold to third-party investors; Abacus holds the Class B residual interest, carrying value $8,243,074 at June 30, 2026 | Servicing fee of 100 basis points of the collateral pool per year |
| LMA Income Series II, LP | A limited partnership Abacus consolidates; its limited partners receive a preferred return of 8.00% to 8.50% by commitment size, and the proceeds are booked as a secured borrowing | Consolidated, so its flows are eliminated; the filing does not call it a related party fund |
The NT speaks of “private funds advised by the Company” with “limited partners”, which fits the four LP Funds and possibly LMA Income Series II, LP, but the filing does not say which (our reading, not the company's statement). Abacus says of itself that it is “the originator and market maker of the assets we purchase and manage”: it buys life insurance policies from people who want to sell them, and it sells policies to the Carlisle Funds, the LP Funds and the Securitized Entity, which is why those sales are reported as related-party revenue. Our page on selling a life insurance policy and the tax on it covers the seller's side.
What “capital account credits” means in the filings: nothing is defined
We searched the full text of the Q2 2026 10-Q, the 2025 10-K and the November 5, 2026 earnings release for “capital account” and found no match. The only description of the credits is in the NT, which first calls them “capital account credits provided to the limited partners” and later “limited partner incentives”. In fund accounting a capital account is a limited partner's equity balance in the fund; a credit to it would be an amount added in that investor's favour. The NT does not say what the credits were for, whether the funds or Abacus bore them, or how they were booked. That gap is the news: a number a holder cannot yet see.
The lines the NT names, before any change
All figures are from the company's November 5, 2026 earnings release (Exhibit 99.1 to the 8-K, accession 0001628280-26-071097), which the NT says may change, and from the 2025 10-K (accession 0001628280-26-017775).
| Line | Q3 2026 | Q3 2025 | Nine months 2026 | Nine months 2025 | Full year 2025 |
|---|---|---|---|---|---|
| Asset management revenue, related party | $4,229,927 | $7,575,553 | $18,085,920 | $21,995,024 | $29,668,675 |
| Life solutions revenue, related party | $34,310,393 | $8,585,697 | $62,365,814 | $25,662,314 | $37,502,458 |
| Total revenues | $76,883,335 | $62,975,156 | $209,293,613 | $163,339,122 | $235,237,636 |
| Two related-party lines as a share of revenue (our arithmetic) | 50.1% | 25.7% | 38.4% | 29.2% | 28.6% |
| Net income | $14,516,582 | $7,075,348 | $28,409,816 | $30,085,303 | Not in the release |
Two readings are fair. The related-party life-solutions line was about four times its year-earlier level in the third quarter (our arithmetic), so more of the reported revenue now comes from dealings with funds the company manages. And the asset management line, the one the NT names first, fell 44% in the third quarter against 2025. Neither fact says anything is misstated; they say where a correction, if there is one, would be felt.
The related party payable and the fund receivables
The NT also names “related party payables”. The balance sheet path in the filings:
| Balance | December 31, 2025 | June 30, 2026 | September 30, 2026 |
|---|---|---|---|
| Related party payable (owed to the funds) | None | $21,473,912 | $3,288,000 |
| Accounts receivable, related party | $9,320,103 | $10,127,137 | $12,104,449 |
| Management and performance fee receivable, related party (noncurrent) | $14,800,140 | $15,187,416 | $14,387,439 |
| Life settlement policies, at fair value | $468,857,929 | $383,044,248 | $369,978,847 |
The Q2 10-Q says the $21,473,912 payable arose from policy purchases from the Carlisle Funds: in the quarter Abacus bought life settlement policies for $21,250,000 from them, against $2,535,875 in the second quarter of 2025. By September 30, 2026 the payable was $3,288,000, a fall of $18,185,912 (our arithmetic). The receivables due from the funds were $26,491,888 at September 30, 2026 (our arithmetic: $12,104,449 plus $14,387,439). These are the balances an evaluation of “transactions between the Company and its related party funds” would test.
What the company has said about the same period before
| Date | Document | What it said |
|---|---|---|
| March 13, 2026 | 10-K for 2025 | Management concluded internal control over financial reporting was effective at December 31, 2025; the company was a non-accelerated filer; AUM about $3.33 billion |
| March 18, 2026 | 8-K, Item 4.01 | Audit Committee approved dismissing Grant Thornton, LLP and engaging KPMG LLP on March 16, 2026; no disagreements or reportable events reported for the period |
| August 10, 2026 | Q2 2026 10-Q | Disclosure controls effective at June 30, 2026; related party payable $21,473,912; senior secured credit facility covenants met at June 30, 2026; total AUM $3,537,264,061 |
| August 13, 2026 | 8-K, Item 8.01 | Board authorized buying up to $100 million of common stock through May 6, 2028 |
| November 5, 2026 | 8-K, Items 2.02 and 8.01 | Third-quarter release; full-year adjusted net income guidance raised to $104.5 million to $106.5 million; $0.22 annual dividend declared |
| November 17, 2026 | NT 10-Q | Cannot file the Q3 10-Q; evaluation may reach back to June 30, 2025; cannot estimate the effect on the November 5 release |
The 8-K of March 18, 2026 is a plain fact of timing: the auditor that signed the 2025 10-K was replaced two days after that 10-K was filed. The 8-K says there were no disagreements and no reportable events. The NT does not mention the auditor at all, and we do not draw a link between the two.
The debt and the ABXL notes
The ABXL notes are the 9.875% Fixed Rate Senior Notes due November 15, 2028. At June 30, 2026 the balance of the fixed unsecured notes was $135,379,475; the company may redeem them at 100% of principal on or after February 15, 2027. The senior secured credit facility had $148,125,000 outstanding at June 30, 2026, and the company said it was in compliance with its financial maintenance covenants. At September 30, 2026 the release shows total debt, net, of $405.0 million and cash of $104,031,612.
We did not read the indenture or the credit agreement for reporting covenants, and the NT does not mention either. So we cannot say whether a late 10-Q has any effect on the notes or the loan. The documents to check are the indenture (U.S. Bank Trust Company, National Association is the trustee named in the 10-Q exhibit list) and the credit agreement, both filed as exhibits.
What happens next, and when
The form itself says a late 10-Q gets extra time “on or before the fifth calendar day following the prescribed due date”, and Abacus says it does not expect to meet even that. On the 2025 10-K's cover the company is a non-accelerated filer, for which a 10-Q is due 45 days after quarter-end under Form 10-Q General Instruction A.1: Monday, November 16, 2026, since the 45th day, November 14, is a Saturday; the extended date would then be Monday, November 23, 2026 (our arithmetic). The Q2 2026 10-Q cover instead ticks “Accelerated filer”, which would make the original date November 9, 2026; the company has not said which status applies for this quarter.
What to watch on EDGAR for CIK 1814287: the Form 10-Q itself; an 8-K under Item 4.02 if the board concludes prior financial statements should no longer be relied upon; any 8-K on a notice from the NYSE about the late filing; any filing about the dividend, which is set for record date December 1, 2026 and payment December 16, 2026; and 8-Ks on the auditor or the audit committee.
What a reader can do with this
This is analysis of public documents, not investment, legal or tax advice.
- If you hold ABX or ABXL: nothing in the filings says the third-quarter numbers are wrong. They say the company cannot yet vouch for them. Keep the November 5, 2026 release and the later 10-Q side by side; the NT says the release itself may change.
- If you are a limited partner in an Abacus fund: ask your fund's administrator in writing whether you received a capital account credit, what it was for, and how it is shown on your statement. The NT is about the company's accounting, not about a change to your account, and it does not say your balance is affected.
- If you sold a policy to Abacus or are about to: the NT does not mention policy sellers or any price paid to them. The company reports $895,747 of “deposits on pending settlements” at September 30, 2026, which is money held against deals not yet closed. For how the sale is taxed, see our page on selling a life insurance policy.
- Set an alert on CIK 1814287 for the 10-Q, any Item 4.02 8-K and any notice of delisting or late filing.
- Read the 10-Q's controls item first when it comes: Item 4 of Part I will say whether disclosure controls were effective, and the notes will show whether any prior period was corrected.
The company “is unable to estimate the extent of any significant changes in previously filed reports”. If a meaningful part of your savings sits in Abacus stock or notes, or in one of its funds, a second opinion on your own numbers may help while that is unresolved.
FAQ
Sources: Abacus Global Management, Inc. (SEC CIK 1814287) Form 12b-25 (NT 10-Q) filed November 17, 2026, accession 0001628280-26-074362; Form 8-K and Exhibits 99.1 and 99.2 filed November 5, 2026, accession 0001628280-26-071097; Form 8-K filed August 13, 2026, accession 0001628280-26-056792; Form 8-K (Item 4.01) filed March 18, 2026, accession 0001628280-26-019440; Form 10-Q for the quarter ended June 30, 2026, accession 0001628280-26-055287; Form 10-K for 2025, accession 0001628280-26-017775; SEC EDGAR filing index for CIK 1814287, checked November 19, 2026. Our arithmetic is labelled where it appears.